MENU
CSBTF
AS OF
Oct 9 closing price
Price
$37.01
Change
+$0.88 (+2.44%)
Capitalization
1.33B
34 days until earnings call
Intraday BUY SELL Signals
+Compare
CSBTF
Stock ticker: OTC
AS OF
Oct 9 closing price
Price
$37.01
Change
+$0.88 (+2.44%)
Capitalization
1.33B

CSBTF stock forecast, quote, news & analysis

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of inventive products for tissue repair and bone regeneration... Show more

CSBTF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for CSBTF with price predictions
Feb 03, 2026

CSBTF in downward trend: 10-day moving average crossed below 50-day moving average on January 21, 2026

The 10-day moving average for CSBTF crossed bearishly below the 50-day moving average on January 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CSBTF as a result. In of 33 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CSBTF moved below its 50-day moving average on January 20, 2026 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for CSBTF entered a downward trend on January 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.706) is normal, around the industry mean (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). CSBTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). CSBTF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (9.251) is also within normal values, averaging (38.937).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CSBTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.77B. The market cap for tickers in the group ranges from 1.86K to 189.57B. ABT holds the highest valuation in this group at 189.57B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -3%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 14%. FEED experienced the highest price growth at 134%, while CYDX experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was 9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 87
Profit Risk Rating: 93
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
CSBTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Wagistrasse 25
Phone
+41 447334747
Employees
80
Web
https://www.kurosbio.com